Quint, T.; Brunner, P.M.; Sinz, C.; Steiner, I.; Ristl, R.; Vigl, K.; Kimeswenger, S.; Neubauer, K.; Pirkhammer, D.; Zikeli, M.;
et al. Dupilumab for the Treatment of Atopic Dermatitis in an Austrian Cohort-Real-Life Data Shows Rosacea-Like Folliculitis. J. Clin. Med. 2020, 9, 1241.
https://doi.org/10.3390/jcm9041241
AMA Style
Quint T, Brunner PM, Sinz C, Steiner I, Ristl R, Vigl K, Kimeswenger S, Neubauer K, Pirkhammer D, Zikeli M,
et al. Dupilumab for the Treatment of Atopic Dermatitis in an Austrian Cohort-Real-Life Data Shows Rosacea-Like Folliculitis. Journal of Clinical Medicine. 2020; 9(4):1241.
https://doi.org/10.3390/jcm9041241
Chicago/Turabian Style
Quint, Tamara, Patrick M. Brunner, Christoph Sinz, Irene Steiner, Robin Ristl, Kornelia Vigl, Susanne Kimeswenger, Katharina Neubauer, Detlev Pirkhammer, Martin Zikeli,
and et al. 2020. "Dupilumab for the Treatment of Atopic Dermatitis in an Austrian Cohort-Real-Life Data Shows Rosacea-Like Folliculitis" Journal of Clinical Medicine 9, no. 4: 1241.
https://doi.org/10.3390/jcm9041241
APA Style
Quint, T., Brunner, P. M., Sinz, C., Steiner, I., Ristl, R., Vigl, K., Kimeswenger, S., Neubauer, K., Pirkhammer, D., Zikeli, M., Hoetzenecker, W., Reider, N., & Bangert, C.
(2020). Dupilumab for the Treatment of Atopic Dermatitis in an Austrian Cohort-Real-Life Data Shows Rosacea-Like Folliculitis. Journal of Clinical Medicine, 9(4), 1241.
https://doi.org/10.3390/jcm9041241